Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,602 public trials 1,046 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Ask Questions (ASQ):Implementation of a Communication Intervention

NCT05025748

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
View Trial Details
Completed

A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer

NCT03695380

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of Arizona Cancer Center, North Tucson, Arizona, United States
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
  • Mayo Clinic-Jacksonville Jacksonville, Florida, United States
  • Florida Hospital Cancer Institute; Clinical Research Department Orlando, Florida, United States
View all 20 locations
View Trial Details
Completed

Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer

NCT04551287

Conditions
Artificial Intelligence, Cervical Cancer, Diagnosing Cervical Cytology Grades and Cancer, +14 more
Locations
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
  • The Third Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Sun Yat-Sen Memorial Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
View Trial Details
Completed

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

NCT00770185

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
View Trial Details
Completed

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

NCT00053794

Conditions
Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +41 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • British Columbia Cancer Agency - Vancouver Island Cancer Centre Vancouver, British Columbia, Canada
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Completed

EP0057 in Combination With Olaparib in Advanced Ovarian Cancer

NCT04669002

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of California Irvine Irvine, California, United States
  • Florida Cancer Specialists and Research Institute Lady Lake, Florida, United States
  • Augusta University Augusta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details

Related conditions